Search
Returning search results with filters:
Remove filter for
Issue: Product safety
Remove filter for
Last updated: January 2019
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 4 of 4 items.
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
PMS-Lactulose Syrup (2019-01-22)
RecallHealth product recall | 2019-01-22
Adrenalin Chloride Sol 1:1000 AMP (2019-01-16)
RecallHealth product recall | 2019-01-16